Vitro Biopharma

Vitro Biopharma is a pharmaceutical research company that specializes in stem cell drugs. The company's core business is the AlloRx Stem Cell platform, on which it conducts trials using mechanized stem cells. The company already has a number of patents for research and development in this area. And it also has approvals from relevant US authorities for clinical trials of AlloRx stem cell treatment for diseases such as Pitt-Hopkins syndrome and post-Covis syndrome. The company's primary focus is the treatment of inflammatory and autoimmune diseases. The company plans to use the funds raised in the IPO to continue trials and development.